Other OTC - Delayed Quote • USD
China Shineway Pharmaceutical Group Limited (CSWYF)
As of August 28 at 9:58 AM EDT. Market Open.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,534,122.0000
3,950,636.0000
3,223,550.0000
2,655,701.0000
Cost of Revenue
1,116,665.0000
1,012,322.0000
813,214.0000
667,855.0000
Gross Profit
3,417,457.0000
2,938,314.0000
2,410,336.0000
1,987,846.0000
Operating Expense
2,446,190.0000
2,215,910.0000
1,868,950.0000
1,558,533.0000
Operating Income
971,267.0000
722,404.0000
541,386.0000
429,313.0000
Net Non Operating Interest Income Expense
91,438.0000
91,801.0000
93,812.0000
71,226.0000
Pretax Income
1,176,905.0000
917,025.0000
720,103.0000
395,024.0000
Tax Provision
293,790.0000
194,252.0000
163,429.0000
99,991.0000
Net Income Common Stockholders
883,115.0000
722,773.0000
556,674.0000
295,033.0000
Diluted NI Available to Com Stockholders
883,115.0000
722,773.0000
556,674.0000
295,033.0000
Basic EPS
1.17
0.96
0.74
0.39
Diluted EPS
1.17
0.96
0.74
0.39
Basic Average Shares
755,400.0000
755,400.0000
755,141.0960
756,494.8720
Diluted Average Shares
755,400.0000
755,400.0000
755,141.0960
756,747.2210
Total Expenses
3,562,855.0000
3,228,232.0000
2,682,164.0000
2,226,388.0000
Net Income from Continuing & Discontinued Operation
883,115.0000
722,773.0000
556,674.0000
295,033.0000
Normalized Income
887,867.8479
724,475.0800
555,087.8040
495,014.2010
Interest Income
91,894.0000
92,431.0000
95,066.0000
87,826.0000
Interest Expense
456.0000
630.0000
1,254.0000
16,600.0000
Net Interest Income
91,438.0000
91,801.0000
93,812.0000
71,226.0000
EBIT
1,177,361.0000
917,655.0000
721,357.0000
411,624.0000
EBITDA
1,177,361.0000
1,103,517.0000
903,743.0000
620,036.0000
Reconciled Cost of Revenue
1,116,665.0000
1,012,322.0000
813,214.0000
667,855.0000
Reconciled Depreciation
--
185,862.0000
182,386.0000
208,412.0000
Net Income from Continuing Operation Net Minority Interest
883,115.0000
722,773.0000
556,674.0000
295,033.0000
Total Unusual Items Excluding Goodwill
-6,334.0000
-2,160.0000
2,052.0000
-191,683.0000
Total Unusual Items
-6,334.0000
-2,160.0000
2,052.0000
-134,889.0000
Normalized EBITDA
1,183,695.0000
1,105,677.0000
901,691.0000
754,925.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
-1,581.1521
-457.9200
465.8040
-48,495.7990
12/31/2020 - 10/5/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade